These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 11796017)
1. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection. Felix NJ; de Serres S; Meyer AA; Ting JP J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017 [TBL] [Abstract][Full Text] [Related]
2. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes. Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735 [TBL] [Abstract][Full Text] [Related]
3. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory. Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768 [TBL] [Abstract][Full Text] [Related]
4. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice. Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867 [TBL] [Abstract][Full Text] [Related]
7. Delayed allograft rejection by the suppression of class II transactivator. Kim TW; Choi YM; Seo JN; Kim JH; Suh YH; Chung DH; Jung KC; Oh KI Exp Mol Med; 2006 Jun; 38(3):210-6. PubMed ID: 16819279 [TBL] [Abstract][Full Text] [Related]
8. Cultured mouse keratinocyte allografts prime for accelerated second set rejection and enhanced cytotoxic lymphocyte response. Cairns BA; deSerres S; Matsui M; Frelinger JA; Meyer AA Transplantation; 1994 Jul; 58(1):67-72. PubMed ID: 8036710 [TBL] [Abstract][Full Text] [Related]
9. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice. Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975 [TBL] [Abstract][Full Text] [Related]
10. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes. Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102 [TBL] [Abstract][Full Text] [Related]
11. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition. Sano Y; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658 [TBL] [Abstract][Full Text] [Related]
12. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777 [TBL] [Abstract][Full Text] [Related]
13. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo. Nevala WK; Paul C; Wettstein PJ J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948 [TBL] [Abstract][Full Text] [Related]
14. Prolonged survival of class II transactivator-deficient cardiac allografts. June Brickey W; Felix NJ; Griffiths R; Zhang J; Wang B; Piskurich JF; Itoh-Lindstrom Y; Coffman TM; Ting JP Transplantation; 2002 Nov; 74(9):1341-8. PubMed ID: 12451276 [TBL] [Abstract][Full Text] [Related]
15. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. Benichou G; Valujskikh A; Heeger PS J Immunol; 1999 Jan; 162(1):352-8. PubMed ID: 9886406 [TBL] [Abstract][Full Text] [Related]
16. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765 [TBL] [Abstract][Full Text] [Related]
17. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. Peeler JS; Niederkorn JY J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767 [TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice. Yamada J; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871 [TBL] [Abstract][Full Text] [Related]
19. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts. Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991 [TBL] [Abstract][Full Text] [Related]
20. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity. Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]